Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001181431-14-006089

Director sold 3,148 shares at $15.98 ($50,296)

  • Director acquired 5,000 shares (option exercise)
  • Director acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

FRYKMAN EDWARD W · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2014-02-06 Grant or award : show line 1 in the form +15,000 22,000 D
2014-02-07 Exercise or conversion : show line 2 in the form +5,000 $10.00 $50,000 27,000 D
2014-02-07 Sale : show line 3 in the form −3,148 $15.98 $50,296 23,852 D
Open-market sales · 3,148 sh · avg $15.98 · $50,296

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2014-02-07 Exercise or conversion : show line 4 in the form Stock Option −5,000 77,500 D
Loading xslF345X03/rrd402026.xml…